CAPTION HEALTH, INC.
United States US-MF-000022891 Last updated 31 May 2026
Is this your brand? Sign in to claim this brand
- Devices
- 8
- Registries
- EUDAMEDGUDIDFDA 510(k)
- FDA recalls
- 1
Catalogue
Caption AI (Caption Guidance + Caption Interpretation) 0.10, 0.11, 1.1, 1.2, 1.3, 1.4 Ref 0.10, 0.11, 1.1, 1.2, 1.3, 1.4
Cardiac Guidance Ref K243065
Caption Guidance Ref 511-00021
511-00022 Ref 511-00022
EUDAMED certificates
TÜV Rheinland LGA Products GmbH 0197 1 certificate
- HZ 2672031-1 Withdrawn
Quality management system EU MDR
- Issued
- 8 May 2025
- Expires
- 20 Mar 2027
- Reason
- Not legal manufacturer
Related companies
Authorised representatives
Notified bodies
FDA recalls
Caption Health, Inc. has one FDA recall record initiated on 2021-05-19, which is listed with a terminated status. The recall pertains to an issue with ultrasound software that may include unintended video frames, potentially affecting automated ejection fraction (AutoEF) and image quality score (IQS) estimates.
2021
- 19 May 2021 Z-2111-2021 Class II Terminated The firm is aware of a issue with ultrasound software that results in unintended video frames being included. This could lead to an incorrect automated ejection fraction (AutoEF) and image quality score (IQS) estimates.
What CAPTION HEALTH, INC. makes
Caption Health, Inc. develops software and tools for cardiac imaging analysis, including automated ejection fraction measurement and guidance systems for interpreting cardiac ultrasound images.
Their portfolio includes Class II and Class IIa devices, with records listed in the EUDAMED database and FDA’s 510(k) registry. The company is based in the United States.
Frequently asked questions
What types of medical devices does Caption Health, Inc. manufacture?
Caption Health, Inc. specializes in software and tools designed for cardiac imaging analysis. Their portfolio includes automated ejection fraction measurement software and guidance systems for interpreting cardiac ultrasound images, such as Caption Interpretation Automated Ejection Fraction Software and Caption Guidance. These tools assist healthcare professionals in analyzing and interpreting cardiac ultrasound data more efficiently.
Where is Caption Health, Inc. based, and how does that affect its regulatory standing?
Caption Health, Inc. is based in the United States. Since the company operates in the U.S., its devices are subject to FDA regulations, which is why their records appear in the FDA’s 510(k) registry. Additionally, their devices are listed in EUDAMED, indicating they are also marketed or intended for use in the European Economic Area, where compliance with EU Medical Device Regulations applies.
Which regulatory registries list Caption Health, Inc.’s devices, and why are these important?
Caption Health, Inc.’s devices are listed in two key regulatory registries: the FDA’s 510(k) database and EUDAMED. The FDA 510(k) registry tracks devices that have undergone premarket notification to demonstrate substantial equivalence to a predicate device, ensuring compliance with U.S. regulations. EUDAMED, on the other hand, is the EU’s central database for medical devices, where manufacturers must register their products to comply with EU Medical Device Regulations, ensuring traceability and transparency in the market.
How are Caption Health, Inc.’s devices classified under regulatory frameworks?
Caption Health, Inc.’s devices fall under Class II and Class IIa classifications. These classifications are determined based on the risk associated with the device. Class II devices pose moderate risks and require special controls to ensure safety and effectiveness, while Class IIa devices are a subset of Class II with slightly lower risk profiles but still require regulatory oversight. The classification influences the regulatory pathway and scrutiny these devices undergo before market authorization.
Why do some of Caption Health’s devices appear in both the FDA’s 510(k) registry and EUDAMED?
Devices listed in both the FDA’s 510(k) registry and EUDAMED are likely marketed or intended for use in both the United States and the European Economic Area. The FDA’s 510(k) process ensures these devices meet U.S. safety and performance standards, while EUDAMED registration confirms compliance with EU Medical Device Regulations. Listing in both databases reflects the company’s global market presence and adherence to multiple regulatory requirements.
Information
- Country
- United States
- Address
- 4 West 4th Ave , San Mateo, United States
- Website
- gehealthcare.com
- [email protected]
- Phone
- (855) 506-4357
- PRRC contact
- Tahir Rizvi
- EUDAMED SRN
- US-MF-000022891
- DUNS number
- 079192179